Literature DB >> 28202739

Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.

Sarah L Tansley, Zoe E Betteridge, Stefania Simou, Thomas S Jacques, Clarissa Pilkington, Mark Wood, Kishore Warrier, Lucy R Wedderburn, Neil J McHugh.   

Abstract

OBJECTIVE: We aimed to establish the prevalence and clinical associations of anti-HMG-CoA-reductase (anti-HMGCR) in a large UK cohort with juvenile myositis.
METHODS: There were 381 patients investigated for anti-HMGCR using ELISA.
RESULTS: Anti-HMGCR autoantibodies were detected in 4 patients (1%). These children had no or minimal rash and significant muscle disease. Muscle biopsies were considered distinctive, with widespread variation in fiber size, necrotic fibers, and chronic inflammatory cell infiltrates; all had prolonged elevation of creatine kinase and all ultimately received biologic therapies.
CONCLUSION: Anti-HMGCR in UK children with myositis are associated with severe disease that is poorly responsive to standard treatment.

Entities:  

Keywords:  AUTOANTIBODIES; PEDIATRIC DERMATOMYOSITIS/POLYMYOSITIS; PEDIATRIC RHEUMATIC DISEASES; PROGNOSIS

Mesh:

Substances:

Year:  2017        PMID: 28202739     DOI: 10.3899/jrheum.160871

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

Review 2.  Autoantibodies in myositis.

Authors:  Neil J McHugh; Sarah L Tansley
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 3.  [Juvenile dermatomyositis-what's new?]

Authors:  C Hinze
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

Review 4.  Immune-Mediated Necrotizing Myopathy.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2018-03-26       Impact factor: 4.592

Review 5.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

6.  Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.

Authors:  Sarah L Tansley; Stefania Simou; Gavin Shaddick; Zoe E Betteridge; Beverley Almeida; Harsha Gunawardena; Wendy Thomson; Michael W Beresford; Angela Midgley; Francesco Muntoni; Lucy R Wedderburn; Neil J McHugh
Journal:  J Autoimmun       Date:  2017-06-26       Impact factor: 7.094

Review 7.  Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.

Authors:  E L Binns; E Moraitis; S Maillard; S Tansley; N McHugh; T S Jacques; L R Wedderburn; C Pilkington; S A Yasin; K Nistala
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-31       Impact factor: 3.054

8.  The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.

Authors:  Sarah L Tansley; Danyang Li; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

9.  Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.

Authors:  Claas H Hinze; Prasad T Oommen; Frank Dressler; Andreas Urban; Frank Weller-Heinemann; Fabian Speth; Elke Lainka; Jürgen Brunner; Heike Fesq; Dirk Foell; Wolfgang Müller-Felber; Ulrich Neudorf; Christoph Rietschel; Tobias Schwarz; Ulrike Schara; Johannes-Peter Haas
Journal:  Pediatr Rheumatol Online J       Date:  2018-06-25       Impact factor: 3.054

Review 10.  Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Authors:  Judith Wienke; Claire T Deakin; Lucy R Wedderburn; Femke van Wijk; Annet van Royen-Kerkhof
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.